Kintara Therapeutics, Inc.
(NASDAQ CM: KTRA)
Rigrodsky Law, P.A. is investigating Kintara Therapeutics, Inc. (“Kintara”) regarding possible breaches of fiduciary duties and other violations of law related to Kintara’s agreement to merge with TuHURA Biosciences, Inc.